Lowe Brockenbrough & Co’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,600
Closed -$207K 275
2021
Q4
$207K Buy
+1,600
New +$196K 0.02% 252
2016
Q2
Sell
-9,000
Closed -$213K 184
2016
Q1
$213K Hold
9,000
0.04% 177
2015
Q4
$202K Sell
9,000
-3,000
-25% -$68.4K 0.03% 178
2015
Q3
$277K Hold
12,000
0.05% 172
2015
Q2
$295K Hold
12,000
0.05% 171
2015
Q1
$301K Hold
12,000
0.05% 172
2014
Q4
$277K Hold
12,000
0.04% 177
2014
Q3
$281K Hold
12,000
0.04% 177
2014
Q2
$278K Hold
12,000
0.04% 173
2014
Q1
$256K Sell
12,000
-50,560
-81% -$1.14M 0.04% 170
2013
Q4
$1.48M Sell
62,560
-600
-0.9% -$13K 0.25% 91
2013
Q3
$1.26M Buy
63,160
+260
+0.4% +$4.93K 0.23% 93
2013
Q2
$1.09M Buy
+62,900
New +$1.04M 0.2% 100

Other funds holding TECH

Lowe Brockenbrough & Co's TECH Position: Q1 2022 in Review

Lowe Brockenbrough & Co sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 1,600 shares — an estimated $207K sold.

Lowe Brockenbrough & Co first reported a position in TECH in Q2 2013 and held it in 13 quarters. The position peaked at $1.48M in Q4 2013. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

  • Lowe Brockenbrough & Co reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
  • Lowe Brockenbrough & Co sold 1,600 Bio-Techne shares in Q1 2022, an estimated $207K.
  • Lowe Brockenbrough & Co first reported a position in Bio-Techne in Q2 2013 and held it in 13 quarters.
  • Lowe Brockenbrough & Co's Bio-Techne position peaked at $1.48M in Q4 2013.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2022, filed 4 May 2022.